TARS logo

Tarsus Pharmaceuticals (TARS) Long term liabilities

Annual long term liabilities:

$71.84M+$40.28M(+127.60%)
December 31, 2024

Summary

  • As of today (May 23, 2025), TARS annual total long term liabilities is $71.84 million, with the most recent change of +$40.28 million (+127.60%) on December 31, 2024.
  • During the last 3 years, TARS annual long term liabilities has risen by +$71.15 million (+10178.25%).
  • TARS annual long term liabilities is now at all-time high.

Performance

TARS Long term liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTARSbalance sheet metrics

quarterly long term liabilities:

$71.98M+$139.00K(+0.19%)
March 31, 2025

Summary

  • As of today (May 23, 2025), TARS quarterly total long term liabilities is $71.98 million, with the most recent change of +$139.00 thousand (+0.19%) on March 31, 2025.
  • Over the past year, TARS quarterly long term liabilities has increased by +$40.45 million (+128.24%).
  • TARS quarterly long term liabilities is now -30.70% below its all-time high of $103.87 million, reached on September 30, 2020.

Performance

TARS quarterly long term liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTARSbalance sheet metrics

Long term liabilities Formula

Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities

TARS Long term liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+127.6%+128.2%
3 y3 years+10000.0%+265.9%
5 y5 years+13.1%-

TARS Long term liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high>+9999.0%-1.4%+268.5%
5 y5-yearat high>+9999.0%-30.7%>+9999.0%
alltimeall timeat high>+9999.0%-30.7%>+9999.0%

TARS Long term liabilities History

DateAnnualQuarterly
Mar 2025
-
$71.98M(+0.2%)
Dec 2024
$71.84M(+127.6%)
$71.84M(-1.5%)
Sep 2024
-
$72.95M(-0.1%)
Jun 2024
-
$73.03M(+131.5%)
Mar 2024
-
$31.54M(-0.1%)
Dec 2023
$31.57M(+61.6%)
$31.57M(+0.5%)
Sep 2023
-
$31.42M(+18.9%)
Jun 2023
-
$26.43M(+7.6%)
Mar 2023
-
$24.55M(+25.7%)
Dec 2022
$19.53M
$19.53M(-0.2%)
Sep 2022
-
$19.57M(-0.2%)
DateAnnualQuarterly
Jun 2022
-
$19.61M(-0.4%)
Mar 2022
-
$19.68M(+2714.9%)
Dec 2021
$699.00K(+15.5%)
$699.00K(-22.8%)
Sep 2021
-
$905.00K(+72.7%)
Jun 2021
-
$524.00K(-13.2%)
Mar 2021
-
$604.00K(-0.2%)
Dec 2020
$605.00K(-99.0%)
$605.00K(-99.4%)
Sep 2020
-
$103.87M(>+9900.0%)
Jun 2020
-
$797.00K(-98.7%)
Dec 2019
$63.50M(+1681.8%)
$63.50M
Dec 2018
$3.56M
-

FAQ

  • What is Tarsus Pharmaceuticals annual total long term liabilities?
  • What is the all time high annual long term liabilities for Tarsus Pharmaceuticals?
  • What is Tarsus Pharmaceuticals annual long term liabilities year-on-year change?
  • What is Tarsus Pharmaceuticals quarterly total long term liabilities?
  • What is the all time high quarterly long term liabilities for Tarsus Pharmaceuticals?
  • What is Tarsus Pharmaceuticals quarterly long term liabilities year-on-year change?

What is Tarsus Pharmaceuticals annual total long term liabilities?

The current annual long term liabilities of TARS is $71.84M

What is the all time high annual long term liabilities for Tarsus Pharmaceuticals?

Tarsus Pharmaceuticals all-time high annual total long term liabilities is $71.84M

What is Tarsus Pharmaceuticals annual long term liabilities year-on-year change?

Over the past year, TARS annual total long term liabilities has changed by +$40.28M (+127.60%)

What is Tarsus Pharmaceuticals quarterly total long term liabilities?

The current quarterly long term liabilities of TARS is $71.98M

What is the all time high quarterly long term liabilities for Tarsus Pharmaceuticals?

Tarsus Pharmaceuticals all-time high quarterly total long term liabilities is $103.87M

What is Tarsus Pharmaceuticals quarterly long term liabilities year-on-year change?

Over the past year, TARS quarterly total long term liabilities has changed by +$40.45M (+128.24%)
On this page